 The volatile stock of Turning Point Therapeutics NASDAQ: TPTX is once again piquing the interest of high risk traders after the company announced encouraging data related to a pivotal trial. Whether the stock can climb the roller coaster back above 100 remains to be seen, but a significant inflection point seems to be here. 